A group of 107 consecutive patients with patent extracranial-intracranial bypasses were followed an average of 25.2 months to determine the long-term results on regional cerebral blood flow (rCBF), transient ischemic attacks (TIAs), and stroke incidence. Average mean rCBF initially rose to 110% at 1 week, then gradually fell to 105% at 6 months, and 85% at 2 years. Maximum increase in cerebral blood flow occurred in patients with middle cerebral artery stenosis or those in the preoperative low flow group, i.e., less than 50 ml/100 gm/min. In the group with TIAs plus mild stroke, the mean rCBF rose to 122% at 1 week, compared to the group with TIAs only who showed a mean increase to 107% at one week. Clinical improvement was excellent or good in 82% of those with TIAs only; in those with TIAs plus mild stroke, 77% had excellent or good relief of TIAs; and in those with mild stroke only, 70% recovered from their neurological deficits. In the 25.2 months of average follow-up, stroke occurred in only 1 patient on the side of the anastomosis, and in 2 patients on the side opposite the anastomosis, giving an average stroke incidence of 1.5% per year.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0090-3019(82)90371-8DOI Listing

Publication Analysis

Top Keywords

cerebral blood
12
blood flow
12
tias mild
12
mild stroke
12
transient ischemic
8
ischemic attacks
8
252 months
8
stroke incidence
8
group tias
8
excellent good
8

Similar Publications

Is Intracranial Pressure Monitoring After Open Cranial Procedures Associated With Outcome?

J Surg Res

January 2025

Division of Trauma and Critical Care, Department of Surgery, Reading Hospital, West Reading, Pennsylvania. Electronic address:

Introduction: It is unclear if intracranial pressure monitoring (ICPM) after open cranial procedures (craniotomy or craniectomy) (OC) for traumatic brain injury is associated with mortality. We hypothesized that ICPM placed early after OC was associated with lower mortality compared to no ICPM or delayed ICPM placement.

Methods: Using 2020-2021 data from the American College of Surgeons Trauma Quality Improvement Program, patients ≥16 y from level 1 and 2 trauma centers who underwent OC were divided into two groups: ICPM placed within 72 h of OC (early) and no ICPM or ICPM placed after 72 h (none/delayed).

View Article and Find Full Text PDF

The main objective of this prospective, multicenter study (REVEAL-CP) was to test children with cerebral palsy-like signs and symptoms for raised 3--methyldopa (3-OMD) blood levels, a biomarker for aromatic L-amino acid decarboxylase deficiency (AADCd). A secondary objective was to characterize the molecular basis for the defective aromatic L-amino acid decarboxylase (AADC) gene product. Patients were identified in pediatric secondary and tertiary care hospitals through database searches and personal communication.

View Article and Find Full Text PDF

Electrochemical aptamer-based (EAB) sensors are a molecular measurement platform that enables the continuous, real-time measurement of a wide range of drugs and biomarkers in situ in the living body. EAB sensors are fabricated by depositing a thiol-modified, target-binding aptamer on the surface of a gold electrode, followed by backfilling with an alkanethiol to form a self-assembled monolayer. And while the majority of previously described EAB sensors have employed hydroxyl-terminated monolayers, a handful of studies have shown that altering the monolayer headgroup can strongly affect sensor performance.

View Article and Find Full Text PDF

A major limiting factor in the success of chimeric antigen receptor (CAR) T cell therapy for the treatment of solid tumors is targeting tumor antigens also found on normal tissues. CAR T cells against GD2 induced rapid, fatal neurotoxicity because of CAR recognition of GD2 normal mouse brain tissue. To improve the selectivity of the CAR T cell, we engineered a synthetic Notch receptor that selectively expresses the CAR upon binding to P-selectin, a cell adhesion protein overexpressed in tumor neovasculature.

View Article and Find Full Text PDF

Microplastics in the bloodstream can induce cerebral thrombosis by causing cell obstruction and lead to neurobehavioral abnormalities.

Sci Adv

January 2025

State Key Laboratory of Environment Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences, Beijing, China.

Human health is being threatened by environmental microplastic (MP) pollution. MPs were detected in the bloodstream and multiple tissues of humans, disrupting the regular physiological processes of organs. Nanoscale plastics can breach the blood-brain barrier, leading to neurotoxic effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!